Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Benzinga.com20d
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Isomorphic Labs, spun out from Google DeepMind in 2021, represents a growing trend of tech giants leveraging AI to streamline the traditionally lengthy and expensive drug development process.
FiercePharma21d
Lilly, Merck team with Purdue University to pioneer new drug production methods
Eli Lilly and ... and smart AI and digital technology, the group said in a Jan. 17 press release. Additionally, the initiative said it was committed to “onshoring” drug manufacturing in ...
STAT3d
Lilly expands GLP-1 research to hypertension, neuro conditions
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...
NBC New York4d
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...
Seeking Alpha1mon
Eli Lilly: Still Much Room To Ride The Weight-Loss Wave
The GLP-1 drug ... Eli Lilly's market share over time. For example, Amgen (AMGN) is developing MariTide and Pfizer (PFE) is developing oral GLP-1 candidates. Again, the similarity to Nvidia in AI ...
Reuters6d
Lilly needs a plan to spur weight-loss drug sales, investors say
Feb 5 (Reuters) - Eli Lilly (LLY.N), opens new tab investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug ...
Investing17d
Eli Lilly stock dips on Novo Nordisk's rival drug data
On Friday, Novo Nordisk released promising trial results for its obesity treatment, amycretin, which showed a significant weight loss in participants, outpacing Eli Lilly's own drug in early ...